domenica, 3 maggio 2026

Notizie AIOM – anno XVII

2 Dicembre 2019

Clinical progression is associated with poor prognosis whatever the treatment line in metastatic castration resistant prostate cancer: The CATS international database

Our goal was to evaluate the impact of progression type (prostate-specific antigen only, radiological or clinical) at initiation of first-, second- and third life-extending therapy (LET) on treatment outcomes in metastatic castration-resistant prostate cancer (mCRPC) patients, ...
Leggi tutto

2 Dicembre 2019

ASTRO Presents First Guideline for RT in Pancreatic Cancer

November 30, 2019 - Recent strides in systemic treatment approaches and the broader application of stereotactic radiation led the American Society for Radiation Oncology (ASTRO) to issue its first guideline regarding radiation therapy (RT) in patients with pancreatic cancer, ...
Leggi tutto

29 Novembre 2019

Enzalutamide Gains Approval in China for mCRPC

November 27, 2019 - China’s National Medical Products Administration has granted approval to enzalutamide for the treatment of patients with metastatic castration-resistant prostate cancer (mCRPC) who are asymptomatic or mildly symptomatic following progression on ...
Leggi tutto

29 Novembre 2019

ASCO Launches New Payment Reform Model to Transform Cancer Care Delivery and Enhance the Quality of Patient Care

November 26, 2019 - The American Society of Clinical Oncology (ASCO) released today a major update to its Patient-Centered Oncology Payment (PCOP) model, an alternative payment model designed to support transformation in cancer care delivery and reimbursement while ensuring ...
Leggi tutto

29 Novembre 2019

FDA Label Change Takes a Bite Out of Prescriptions

November 26, 2019 - Immunotherapy prescriptions for patients with metastatic bladder cancer declined rapidly after the FDA altered the indications of 2 drugs, suggesting that practicing oncologists can keep pace with changes associated with the agency’s accelerated ...
Leggi tutto

29 Novembre 2019

29 novembre 2019 – Attivazione Registro Radio-223 dicloruro (Bayer)

28 Novembre 2019

25 novembre 2019 – Rapporto “L’uso degli antibiotici in Italia” 2018

28 Novembre 2019

25 novembre 2019 – Comunicazione EMA su Alemtuzumab (Genzyme)

28 Novembre 2019

26 novembre 2019 – Antibiotici: dai dati del Rapporto AIFA informazioni utili e proposte per un uso più appropriato

28 Novembre 2019

27 novembre 2019 – Dichiarazione delle Autorità mondiali di regolamentazione dei medicinali sulla lotta alla resistenza antimicrobica